Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Example Chemotherapy Medication Request — Doxorubicin

Raw json | Download

{
  "resourceType" : "MedicationRequest",
  "id" : "ChemotherapyMedicationRequestExample",
  "meta" : {
    "profile" : [
      🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-chemotherapy-medication-request"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest ChemotherapyMedicationRequestExample</b></p><a name=\"ChemotherapyMedicationRequestExample\"> </a><a name=\"hcChemotherapyMedicationRequestExample\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-nccp-chemotherapy-medication-request.html\">NCCP Chemotherapy Medication Request</a></p></div><p><b>Cycle Day Start Extension</b>: 1</p><p><b>Cycle Day End Extension</b>: 1</p><p><b>Clinical Category Extension</b>: CHEMOTHERAPY</p><p><b>identifier</b>: <a href=\"NamingSystem-nccp-med-request-id.html\" title=\"Unique identifier for each medication request (prescription). Format: MR-YYYY-NNNNN.\">NCCPMedRequestId</a>/MR-2026-00301</p><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/medicationrequest-category inpatient}\">Inpatient</span></p><p><b>medication</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs DOXORUBICIN}\">Doxorubicin</span></p><p><b>subject</b>: <a href=\"Patient-example-patient.html\">Mary Wanjiku  Female, DoB: 1975-06-15</a></p><p><b>authoredOn</b>: 2026-01-10</p><p><b>requester</b>: <a href=\"Practitioner-example-practitioner.html\">Practitioner James Otieno </a></p><p><b>reasonReference</b>: <a href=\"Condition-example-condition.html\">Condition C50 — Malignant neoplasm of breast</a></p><p><b>basedOn</b>: <a href=\"CarePlan-example-careplan.html\">CarePlan: status = active; intent = plan</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>route</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/route-of-administration-cs RT10036}\">Intravenous</span></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>60 mg/m2<span style=\"background: LightGoldenRodYellow\"> (Details: Kenya Oncology Unit of Measure Code System  codeMG-PER-M2 = 'mg/m²')</span></td></tr></table></blockquote></div>"
  },
  "extension" : [
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-day-start-extension",
      "valueInteger" : 1
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-day-end-extension",
      "valueInteger" : 1
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-clinical-category-extension",
      "valueCode" : "CHEMOTHERAPY"
    }
  ],
  "identifier" : [
    {
      "system" : "https://nshr-uat.sha.go.ke/fhir/med-request-id",
      "value" : "MR-2026-00301"
    }
  ],
  "status" : "active",
  "intent" : "order",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
          "code" : "inpatient",
          "display" : "Inpatient"
        }
      ]
    }
  ],
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs",
        "code" : "DOXORUBICIN",
        "display" : "Doxorubicin"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/example-patient"
  },
  "authoredOn" : "2026-01-10",
  "requester" : {
    🔗 "reference" : "Practitioner/example-practitioner"
  },
  "reasonReference" : [
    {
      🔗 "reference" : "Condition/example-condition"
    }
  ],
  "basedOn" : [
    {
      🔗 "reference" : "CarePlan/example-careplan"
    }
  ],
  "dosageInstruction" : [
    {
      "route" : {
        "coding" : [
          {
            "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/route-of-administration-cs",
            "code" : "RT10036",
            "display" : "Intravenous"
          }
        ]
      },
      "doseAndRate" : [
        {
          "doseQuantity" : {
            "value" : 60,
            "unit" : "mg/m2",
            "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/unit-of-measure-cs",
            "code" : "MG-PER-M2"
          }
        }
      ]
    }
  ]
}